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Schizophrenia is a severe neurological dis-
order characterized by psychotic symp-
toms, emotional distress, and cognitive
deficits. It results from an amalgam of ge-
netic, developmental, and environmental
factors. In the last decade, several studies
identified Nrg1 and its receptor ErbB4 as
major schizophrenia-risk genes (Stefansson
et al., 2002; Norton et al., 2006). More-
over, behavioral studies on different Nrg1
and ErbB4 mutant mice revealed various
endophenotypes that are believed to be
useful formodeling schizophrenia inmice
(e.g., hyperactivity in response to novelty,
hypersensitivity to psychostimulants, and
deficits in working memory tasks). Similar
phenotypes were shown in mice expressing
mutated BACE-1 (the extracellular Nrg1-
cleavage enzyme) (Savonenko et al., 2008)
or Aph1B/C--secretase (the Nrg1 intracel-
lular proteolytic enzyme) (Dejaegere et al.,
2008). Together, these findings suggest that
perturbedNrg1signaling leads to functional
deficits that correlate with schizophrenia.
Nonetheless, Nrg1 and ErbB4 mutants do
not display overtmorphological defects in
the brain and the precise role of Nrg1/
ErbB4 signaling in the nervous system re-
mains elusive.
In addition to canonical forward sig-
naling via ErbB family receptors, the
membrane-bound form of Nrg1 can also
activate reverse signaling. Upon synaptic
activation or receptor binding, membrane-
associated type III Nrg1 is cleaved by
-secretase to release the intracellular do-
main (NRG1-ICD), which translocates to
the nucleus where it regulates gene ex-
pression (Bao et al., 2003, 2004). Recently,
it was shown that Nrg1/ErbB4 forward
signaling promotes the formation of in-
hibitory circuits in the cortex (Fazzari et
al., 2010). Chen et al. (2010) show that
Nrg1 reverse signaling is important for the
development of the dendritic arbor of py-
ramidal neurons (PNs).
To address the function of type III
Nrg1 in PNs in vivo, the authors com-
pared the morphology of dendritic arbor
of neurons in type III Nrg1-deficient and
wild-type (WT) mice. The histological
analysis of mutant and control brains re-
vealed that the total length and number of
branches of basal dendrites were greatly
reduced in type III Nrg1-deficient versus
WT neurons. Because axon length could
not bemeasured efficiently in vivo, the au-
thors used primary cortical cultures.
Mimicking the in vivo data, the type III
Nrg1 mutant neurons showed a clear re-
duction in dendritic development in vitro.
In addition, the axonal length, but not the
axonal branching, was reduced in type III
Nrg1-deficient neurons.
To elucidate the molecular mecha-
nisms involved in type III NRG1 function
in the development of dendrites and ax-
ons, Chen et al. (2010) verified that Nrg1
reverse signaling occurs in cortical cul-
tures by showing that ErbB4 binding
stimulated translocation of NRG1-ICD to
the nucleus and activated transcription of
a luciferase reporter gene. Furthermore,
they found mutations in the intracellular
portion of Nrg1 (V321A/V322A and
K329A/Q330A) that abolished the tran-
scriptional activation. The actual translo-
cation of control and mutant NRG1-ICD
to the nucleus was also measured by im-
munofluorescence, confirming the results
of the luciferase assay. Consistent with
this finding, a similar mutation (V321L)
that is associated with schizophrenia
(Walss-Bass et al., 2006) was previously
shown to impair -secretase cleavage of
Nrg1 (Dejaegere et al., 2008).
Interestingly, the immunofluorescence
shows the presence of NRG1-ICD in the
nucleus even without ErbB4 stimulation.
Consistently, in the luciferase assay, WT
Nrg1 displays a basal level of transcrip-
tional activation in absence of exogenous
ErbB4 that is higher than the uncleavable
forms. Although Chen et al. (2010) do
not clarify whether this difference is sta-
tistically significant, these experiments
suggest that a small but considerable
amount of WT Nrg1 was processed in ab-
sence of exogenous ErbB4 stimulation. As
the authors subsequently claim that type
III Nrg1 function is ErbB4 independent, it
would be important to clarify this issue.
Next, Chen et al. (2010) tried to res-
cue the dendritic and axonal phenotype
in type III Nrg1-null neurons by ex-
pressing WT or mutant forms of type III
Nrg1 in vitro. They found that both res-
idues V321/V322 and K329/Q330, which
are required for type III Nrg1 cleavage and
nuclear translocation, were necessary to
rescue the dendritic phenotype. In con-
trast, even the uncleavable Nrg1 mutants
could rescue the axonal phenotype, show-
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ing that Nrg1-ICD processing is not es-
sential for axonal maturation.
Because Nrg1-ICD transcriptional ac-
tivation is triggered by receptor binding,
the authors asked whether type III Nrg1
actions were dependent on endogenous
ErbB4. Intriguingly, the authors showed
that pyramidal neurons from ErbB4-
deficient mice displayed normal mor-
phology. This result suggests that ErbB4
plays a redundant role in Nrg1 backward
signaling, but it still leaves open the possi-
bility that another receptor of the ERBB
family might activate Nrg1-ICD in corti-
cal neurons (Fox and Kornblum, 2005).
To study this issue, we believe that it
would be valuable to quantify the amount
of Nrg1 that is cleaved to release Nrg1-
ICD in ErbB4 mutant cultures. In addi-
tion, it would be informative to test the
effect of exogenous ErbB4 stimulation on
dendritic arborization; if the amount of
Nrg1-ICD transcriptional activation pro-
portionally increases dendritic arboriza-
tion, exogenous ErbB4 stimulation is
expected to enhance dendritic develop-
ment in a dose-dependent manner. Alter-
natively, Nrg1-ICD activity could be just a
permissive factor. In this case, a low level
of Nrg1-ICD transcriptional activation
might be necessary and sufficient to allow
proper dendritic development, even in
absence of ErbB4.
In summary, the work by Chen et al.
(2010) provides important evidence that
the Nrg1 is differentially required in PNs
for axonal and dendritic development. In
particular, Nrg1 reverse signaling, initi-
ated by -secretase-mediated intracellular
cleavage, is necessary for dendritic devel-
opment of cortical neurons both in vitro
and in vivo. This suggests a dual function
for Nrg1 in sculpting the cortical wiring.
On one hand, Nrg1 forward signaling via
ErbB4, which is mainly expressed in
parvalbumin-positive interneurons that
target the soma and the axonal initial seg-
ment of PNs, promotes the establishment
of negative feedback inhibitory circuits on
PNs (Fazzari et al., 2010). In particular,
ErbB4 is required both for the formation
of excitatory synapses onto parvalbumin-
positive interneurons and for the forma-
tion of inhibitory synapses over cortical
pyramidal cells. On the other hand, Chen
and colleagues (2010) suggest that reverse
signaling via Nrg1 shapes cortical cir-
cuitry by promoting the development of
PNs dendrites.
Nonetheless, several issues remain to
be elucidated about the role of Nrg1-ICD
in vivo. First, the histology of the brains of
type III Nrg1-deficient mice should be
carefully analyzed to explain the surpris-
ing finding that, despite a dramatic de-
crease in PN dendritic length (50%),
these mutant mice do not display a de-
crease in cortical volume. Notably, a de-
creased cortical volume is a typical
hallmark of schizophrenia. Second, since
Nrg1-ICD regulates the expression of
PSD-95, a major postsynaptic scaffolding
protein of excitatory synapses (Bao et al.,
2004), it would be useful to determine
whether type III Nrg1-deficient mice dis-
play defects in synaptogenesis and/or in
excitatory transmission between PNs.
Third, it was reported that Nrg1-ICD pre-
vents neuronal apoptosis by regulating
the expression of apoptotic genes (Bao et
al., 2003). This introduces a caveat to the
Chen et al. (2010) study since the im-
paired neuritic development might also
be explained by distress resulting from an
increased sensitivity to apoptotic factors.
Finally, the molecular mechanisms of
Nrg1 reverse signaling remain to be clari-
fied. By definition, reverse signaling is
elicited by the intracellular domain of a
ligand upon binding to its receptor. How-
ever, the authors claim that Nrg1 back-
ward signaling is independent of ErbB4
and of ERBB receptors kinase activity. It
was previously shown that -secretase-
dependent cleavage of type III Nrg1 can
also be activated by synaptic activity (Bao
et al., 2004). Nevertheless, synaptic activ-
ity hardly explains the in vitro phenotype
at 3 d in vitro reported by Chen et al.
(2010) because synaptic activity is not yet
present in these young cultures. In addi-
tion, the fact that uncleavable Nrg1 ex-
pression in type III Nrg1-deficient PNs
rescues the axonal phenotype suggests a
cell-autonomous function that is inde-
pendent of Nrg1-ICD transcriptional
activity.
In conclusion, Chen and colleagues
(2010) provide convincing evidence that
type III Nrg1 reverse signaling promotes
dendritic arborization in cortical PNs. Re-
markably, this Nrg1-ICD function seems
independent of ErbB4, suggesting a het-
erodox form of backward signaling.
These findings support the relevance of
Nrg1 function in cortical development;
nonetheless, more work remains to be
done to understand the role of Nrg1 in
cortical wiring and in the etiology of
schizophrenia.
References
Bao J, Wolpowitz D, Role LW, Talmage DA
(2003) Back signaling by the Nrg-1 intracel-
lular domain. J Cell Biol 161:1133–1141.
Bao J, Lin H, Ouyang Y, Lei D, Osman A, Kim
TW,Mei L,Dai P,Ohlemiller KK,AmbronRT
(2004) Activity-dependent transcription reg-
ulation of PSD-95 by neuregulin-1 and Eos.
Nat Neurosci 7:1250–1258.
Chen Y, Hancock ML, Role LW, Talmage DA
(2010) Intramembranous valine linked to
schizophrenia is required for neuregulin 1
regulation of the morphological development
of cortical neurons. J Neurosci 30:9199–9208.
Dejaegere T, Serneels L, Scha¨ferMK,VanBiervliet
J, Horre´ K, Depboylu C, Alvarez-Fischer D,
Herreman A, Willem M, Haass C, Ho¨glinger
GU, D’Hooge R, De Strooper B (2008) Defi-
ciency of Aph1B/C-gamma-secretase disturbs
Nrg1 cleavage and sensorimotor gating that
can be reversed with antipsychotic treatment.
Proc Natl Acad Sci U S A 105:9775–9780.
Fazzari P, Paternain AV, Valiente M, Pla R, Luja´n
R, Lloyd K, Lerma J, Marín O, Rico B (2010)
Control of cortical GABA circuitry develop-
ment by Nrg1 and ErbB4 signalling. Nature
464:1376–1380.
Fox IJ, Kornblum HI (2005) Developmental
profile of ErbB receptors in murine central
nervous system: implications for functional
interactions. J Neurosci Res 79:584–597.
Norton N, Moskvina V, Morris DW, Bray NJ,
Zammit S,Williams NM,Williams HJ, Preece
AC, Dwyer S, Wilkinson JC, Spurlock G,
Kirov G, Buckland P, Waddington JL, Gill M,
Corvin AP, Owen MJ, O’Donovan MC
(2006) Evidence that interaction between
neuregulin 1 and its receptor erbB4 increases
susceptibility to schizophrenia. Am J Med
Genet B Neuropsychiatr Genet 141:96–101.
Savonenko AV, Melnikova T, Laird FM, Stewart
KA, Price DL, Wong PC (2008) Alteration
of BACE1-dependent NRG1/ErbB4 signal-
ing and schizophrenia-like phenotypes in
BACE1-null mice. Proc Natl Acad Sci U S A
105:5585–5590.
Stefansson H, Sigurdsson E, Steinthorsdottir V,
Bjornsdottir S, Sigmundsson T, Ghosh S,
Brynjolfsson J, Gunnarsdottir S, Ivarsson O,
Chou TT, Hjaltason O, Birgisdottir B, Jonsson
H, Gudnadottir VG, Gudmundsdottir E,
BjornssonA, IngvarssonB, IngasonA,Sigfusson
S,Hardardottir H, et al. (2002) Neuregulin 1
and susceptibility to schizophrenia. Am J
Hum Genet 71:877–892.
Walss-Bass C, Liu W, Lew DF, Villegas R,
Montero P, Dassori A, Leach RJ, Almasy L,
Escamilla M, Raventos H (2006) A novel
missense mutation in the transmembrane do-
main of neuregulin 1 is associatedwith schizo-
phrenia. Biol Psychiatry 60:548–553.
15006 • J. Neurosci., November 10, 2010 • 30(45):15005–15006 Pedrique and Fazzari • Journal Club
